Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Generative AI is no longer a single thing. Ask, “What is the best generative AI tool for writing PR content?” or “Is keyword targeting as impossible as spinning straw into gold?,” and each engine will ...

Generate Capital PBC, an investment firm that has raised more than $14 billion since 2014 to bankroll largely US-based sustainable projects, has cut staff as the withdrawal of US policy support upends ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Start by making a list of the devices and appliances you need to power and add up the ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The latest long-term support (LTS) release of the JDK is Java 21, which was released in ...

DeepMind, Google’s AI research org, has unveiled a model that can generate an “endless” variety of playable 3D worlds. Called Genie 2, the model — the successor to DeepMind’s Genie, which was released ...

Can ChatGPT generate images? With all the various ChatGPT features and models OpenAI has announced in the past year, it's hard to keep track of what's actually live and accessible to the average user.

Novartis has inked a deal potentially worth more than $1 billion with Flagship-founded Generate:Biomedicines to develop protein therapeutics across multiple indications. The companies did not disclose ...

Novartis will apply Generate:Biomedicines’ generative artificial intelligence (AI) platform to discover and develop protein therapeutics for multiple unspecified disease areas, through a collaboration ...